[]

Find Clinical Drug Pipeline Developments & Deals for Alanyl Glutamine

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          University of Zurich

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          University of Zurich

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Lead Product(s) : Alanyl Glutamine

                          Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                          Study Phase : Phase IV

                          Sponsor : Swiss National Science Foundation | Fresenius Kabi AB Brunna | University Hospital Zürich

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Peptide

                          Upfront Cash : Inapplicable

                          May 05, 2014

                          Lead Product(s) : Alanyl Glutamine

                          Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                          Highest Development Status : Phase IV

                          Sponsor : Swiss National Science Foundation | Fresenius Kabi AB Brunna | University Hospital Zürich

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          University of Texas at Austin

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          University of Texas at Austin

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          June 20, 2012

                          Lead Product(s) : Alanyl Glutamine

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Kyowa Hakko Bio

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank